Online Only Articles

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

University of Bologna, Italy
Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
University of Manchester and The Christie NHS Foundation Trust, UK
Hospital Universitario de Salamanca, Spain
Guy’s Hospital, London, UK
Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
Aarhus University Hospital, Denmark
Hôpital Henri Mondor, Créteil, France
Hôpital Saint Louis, Paris, France
Institut Català d’Oncologia, Barcelona, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
NIHR/CRUK Experimental Cancer Medicine Centre, University of Southampton, UK
University Medical Center Groningen, University of Groningen, The Netherlands
Kyowa Kirin Pharmaceutical Development, Inc., Galashiels, Scotland
Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
Unité GRITA, Université de Lille 2, France
Vol. 101 No. 10 (2016): October, 2016 https://doi.org/10.3324/haematol.2016.146977